STOCK TITAN

November 2024 Stock Losers on News

Ranked by the close-to-close change of the trading session each announcement landed in. How this is measured.

Data as of the trading session of , 19 of 20 completed market sessions produced ranked moves. That date is the last ranked session, not the last priced one, so follow-through dates run later.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

See the biggest gainers of November 2024 Every stock ranked by its November 2024 gain, with or without news

100

Ranked drops

-83.78%

Largest, SAVA

94.9%

Below baseline, day +5

3.4%

Median deeper below baseline, day +5

Filter and sort
Rows

100 ranked drops in November 2024

Skip the ranked rows and go to the month summary

Every percentage on a row, the follow-through readings included, is measured against that row's own pre-news close, which the row names. A day +5 reading is therefore the move from before the announcement, not a further change on top of the headline percentage.

Rows are ordered by the move measured when the board was ranked. A percentage recomputed from the session's own closing prices can sit a little above or below its neighbours; the rank is the one the measured move gave the row.

Rank Symbol close to close Session Catalyst Announcement
1 SAVA -83.78% against the close of 11/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results catalyst from a later release the same session Cassava Sciences to Hold Corporate Update on November 25th

20:01 ET after hours

2 EYEN -70.04% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Eyenovia Provides Update on Phase 3 CHAPERONE Study

07:00 ET premarket

3 OTLK -65.24% against the close of 11/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Outlook Therapeutics® Announces Preliminary Topline Results of NORSE EIGHT Clinical Trial

06:50 ET premarket

4 SAVE -59.32% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Spirit Airlines Files Form 12b-25

18:49 ET after hours

5 SOWG -56.78% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Sow Good Reports Third Quarter 2024 Results

08:00 ET premarket

6 IAUX -56.07% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings i-80 Gold Reports Q3 2024 Operating Results and New Development Plan

18:34 ET after hours

7 XFOR Also on the opposite board this month on both boards -53.17% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results X4 Pharmaceuticals Announces Positive Results from Completed Six-Month Phase 2 Trial of Mavorixafor in Chronic Neutropenia (CN)

06:01 ET premarket

8 CATX -51.38% against the close of 11/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium

07:15 ET premarket

9 SIDU -47.11% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Sidus Space Announces Pricing of Public Offering

21:11 ET after hours

10 NVCT -46.30% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Nuvectis Pharma Reports Encouraging NXP800 Interim Data Supporting Ongoing Enrollment in Phase 1b Study in Patients with Platinum-Resistant ARID1a-Mutated Ovarian Cancer

07:00 ET premarket

11 EVH -45.62% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Evolent Announces Third Quarter 2024 Results

16:10 ET after hours

12 PYXS -45.03% against the close of 11/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data

16:05 ET after hours

13 APPS -44.75% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Digital Turbine Reports Fiscal 2025 Second Quarter Financial Results

17:20 ET after hours

14 VRCA -44.23% against the close of 11/04/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

16:05 ET after hours

15 NGNE More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -44.08% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

16:01 ET after hours

16 NGNE More than one ranked move this month Also on the opposite board this month 2+ ranked moves on both boards -42.58% against the close of 11/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Neurogene Provides Update on NGN-401 Gene Therapy Clinical Trial for Rett Syndrome

06:45 ET premarket

17 MQ -42.52% against the close of 11/04/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Marqeta Reports Third Quarter 2024 Financial Results

16:05 ET after hours

18 INSG -40.36% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Inseego Reports Third Quarter 2024 Financial Results

16:05 ET after hours

19 KXIN Also on the opposite board this month release reads positive on both boards -40.19% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition Release reads positive, stock fell 40.19% Kaixin Holdings Explores Strategic Alternatives with Potential Acquisition in Crypto Mining Sector

08:30 ET premarket

20 RAPT -39.45% against the close of 11/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Based on Recent FDA Feedback RAPT Therapeutics Stops Zelnecirnon Program Following Clinical Hold Due to Single SAE of Severe Liver Injury

08:00 ET premarket

21 RMTI -39.14% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Rockwell Medical Reports Third Quarter 2024 Earnings, Generates Profitability on a Cash Flow and Adjusted EBITDA Basis for the Second Consecutive Quarter

06:00 ET premarket

22 PACS More than one ranked move this month 2+ ranked moves -38.76% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement PACS Group Provides Preliminary Third Quarter Operational Metrics

06:00 ET premarket

23 LXRX release reads positive -38.69% against the close of 10/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
FDA & Regulatory Release reads positive, stock fell 38.69% Lexicon Announces Outcome of FDA Advisory Committee for Zynquista™ (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease

18:54 ET after hours

24 DWTX -37.71% against the close of 11/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

08:45 ET premarket

25 ALTO -37.63% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Alto Ingredients, Inc. Enters CO2 Transportation and Sequestration Agreement with Vault 44.01

16:05 ET after hours

26 TNGX -37.45% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program

07:00 ET premarket

27 STIM -37.27% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Neuronetics Reports Record Third Quarter 2024 Financial and Operating Results

07:10 ET premarket

28 LILM -36.97% against the close of 11/04/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Lilium Launches M&A Process with KPMG, Targets Program Continuation Towards First Flight and Certification

04:00 ET premarket

29 ALVR -36.93% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina

06:00 ET premarket

30 KURA release reads positive -36.77% against the close of 11/20/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Contract / Partnership Release reads positive, stock fell 36.77% Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

17:00 ET after hours

31 PIII -35.99% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings P3 Health Partners Announces Third Quarter 2024 Results

16:05 ET after hours

32 RVNC -35.99% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Revance Reports Third Quarter 2024 Financial Results, Provides Corporate Update

16:05 ET after hours

33 SYM -35.86% against the close of 11/26/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Symbotic Provides Update to Restatement of Fiscal Year 2024 Financial Results and First Quarter of Fiscal Year 2025 Outlook

07:00 ET premarket

34 PGY -35.58% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Pagaya Reports Third Quarter and Nine Months Ended 2024 Results

07:19 ET premarket

35 SSP -35.51% against the close of 11/01/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Scripps reports Q3 2024 financial results

07:30 ET premarket

36 MRVI -35.27% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Maravai LifeSciences Reports Third Quarter 2024 Financial Results

16:01 ET after hours

37 RAIL -35.26% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings FreightCar America, Inc. Reports Third Quarter 2024 Results

07:30 ET premarket

38 ALEC -35.10% against the close of 11/25/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Alector Announces Results from AL002 INVOKE-2 Phase 2 Trial in Individuals with Early Alzheimer’s Disease and Provides Business Update

16:05 ET after hours

39 AVNW -34.54% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Aviat Networks Announces Fiscal 2025 First Quarter and Three Month Financial Results

16:01 ET after hours

40 MFH release reads positive -34.50% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Release reads positive, stock fell 34.50% Mercurity Fintech CEO Highlights Strategic Vision Following Participation in Nasdaq Small-Cap Forum

09:05 ET premarket

41 AGL -34.05% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings agilon health Reports Third Quarter 2024 Results

16:00 ET after hours

42 OPRX -33.98% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings OptimizeRx Reports Third Quarter 2024 Financial Results

16:05 ET after hours

43 MAMO -31.25% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Massimo Group Reports Third Quarter 2024 Financial Results

08:31 ET premarket

44 OPTX -31.13% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Third Quarter 2024 Financial Results

16:37 ET after hours

45 HRTX -30.43% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

07:55 ET premarket

46 JELD -29.79% against the close of 11/04/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings JELD-WEN Reports Third Quarter 2024 Results

16:30 ET after hours

47 BRNS -29.70% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results catalyst from a later release the same session Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B

11:01 ET intraday

48 HTLM -29.56% against the close of 11/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings HomesToLife Ltd Announces Financial Results for First Six Months of 2024; Company to hold Conference Call to Discuss Results Nov. 26 at 8:30 am ET

07:14 ET premarket

49 QUBT Also on the opposite board this month on both boards -29.55% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Quantum Computing, Inc. Announces Registered Direct Offering of $40 Million Priced At-The-Market Under Nasdaq Rules

23:00 ET after hours

50 AMN -29.01% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings AMN Healthcare Announces Third Quarter 2024 Results

16:15 ET after hours

51 LCTX -28.99% against the close of 11/19/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

08:00 ET premarket

52 NRGV -28.86% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Energy Vault Reports Third Quarter 2024 Financial Results

16:05 ET after hours

53 LEU -28.79% against the close of 11/01/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Centrus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes due 2030

06:52 ET premarket

54 BRAG -28.54% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Bragg Gaming Group Announces Record Third Quarter 2024 Revenue of EUR 26.2 Million (USD 29.3 Million)

07:00 ET premarket

55 BW -28.46% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Babcock & Wilcox Enterprises Reports Third Quarter 2024 Results

16:34 ET after hours

56 FIGS -28.34% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings FIGS Releases Third Quarter 2024 Financial Results

16:05 ET after hours

57 LPSN -28.20% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings LivePerson Announces Third Quarter 2024 Financial Results

16:30 ET after hours

58 TISI -28.11% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Team, Inc. Reports Third Quarter 2024 Results

16:45 ET after hours

59 PACS More than one ranked move this month 2+ ranked moves -27.78% against the close of 11/01/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
M&A / Acquisition PACS Group Closes Acquisition of Operations at 8 Facilities in Pennsylvania, Including Real Estate on 4

16:05 ET after hours

60 LTRX -27.69% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lantronix Reports Results for First Quarter of Fiscal 2025

16:15 ET after hours

61 LEV More than one ranked move this month 2+ ranked moves -27.67% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings LION ELECTRIC ANNOUNCES THIRD QUARTER 2024 RESULTS

17:05 ET after hours

62 CLVT -27.16% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Clarivate Reports Third Quarter 2024 Results

06:00 ET premarket

63 GRPN -27.03% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution Groupon Announces $197 Million Financing Transaction

16:57 ET after hours

64 AILE -27.00% against the close of 11/15/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement iLearningEngines Announces Leadership Appointments

09:30 ET intraday

65 CATO -26.81% against the close of 11/21/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Buyback / Dividend THE CATO CORPORATION SUSPENDS REGULAR QUARTERLY DIVIDEND

07:00 ET premarket

66 CURI -26.62% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CuriosityStream Reports Q3 2024 Earnings Results

16:05 ET after hours

67 ANGI -26.34% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings IAC Earnings Release and Letter to Shareholders Available on Company's Website

16:10 ET after hours

68 CE -26.32% against the close of 11/04/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Celanese Corporation Reports Third Quarter Earnings

16:13 ET after hours

69 SPNS -26.24% against the close of 11/08/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Sapiens Reports Third Quarter 2024 Financial Results

05:43 ET premarket

70 GTN -26.08% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Gray Announces Third Quarter Financial Results, Additional Cost Containment Initiatives, and Approximately $500 Million of Full-Year 2024 Political Ad Revenue and Projected $500 Million Full-Year 2024 Net Debt Reduction

06:00 ET premarket

71 EVAX -26.05% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance Evaxion receives and appeals delisting determination from Nasdaq, remains committed to Nasdaq listing

08:00 ET premarket

72 YOU -25.80% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CLEAR Announces Third Quarter 2024 Earnings

06:00 ET premarket

73 TLPH -25.61% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update

16:05 ET after hours

74 SNDX -25.57% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Clinical Trial Results Syndax Announces Positive Pivotal Topline Results from Relapsed or Refractory mNPM1 AML Cohort in AUGMENT-101 Trial of Revumenib

07:00 ET premarket

75 LTBR -25.51% against the close of 10/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Lightbridge Provides Business Update and Announces Third Quarter 2024 Financial Results

16:05 ET after hours

76 PSFE -25.32% against the close of 11/12/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Paysafe Reports Third Quarter 2024 Results; Reaffirms Full Year Outlook

06:55 ET premarket

77 COMM -25.18% against the close of 11/06/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings CommScope Reports Third Quarter 2024 Results

06:30 ET premarket

78 JRVR -25.08% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings James River Announces Third Quarter 2024 Results, Strategic Actions

16:10 ET after hours

79 AMPG -25.00% against the close of 11/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution AmpliTech Group Announces Pricing of $1.4 Million Registered Direct Offering, Priced At-The-Market

09:00 ET premarket

80 GDHG -25.00% against the close of 11/18/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Golden Heaven Group Holdings Ltd. Secures Investment of US$25.2 Million and Enters Into Amendments to Outstanding Warrants

09:00 ET premarket

81 SCWO -24.82% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution 374Water Inc. Announces Pricing of $12.2 Million Registered Direct Offering

08:00 ET premarket

82 CRDF -24.69% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Cardiff Oncology Reports Third Quarter 2024 Results and Provides Business Update

16:05 ET after hours

83 OKLO -24.62% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Oklo Publishes Third Quarter 2024 Financial Results and Business Update

16:05 ET after hours

84 TVGN -24.42% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability

16:43 ET after hours

85 TSSI -24.37% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement TSS, INC. Reports Third Quarter Revenue of $70.1 Million, Up 689%

16:01 ET after hours

86 VERI -23.93% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Veritone Reports Third Quarter 2024 Results

08:07 ET premarket

87 ICAD -23.72% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings iCAD Reports Financial Results for Third Quarter Ended September 30, 2024

16:01 ET after hours

88 ZK -23.68% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings ZEEKR Reports Third Quarter 2024 Unaudited Financial Results

23:00 ET after hours

89 ASPI -23.53% against the close of 11/25/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement ASP Isotopes Inc. Responds to Short Seller Report

15:34 ET intraday

90 BDSX -23.53% against the close of 10/31/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Biodesix Announces Third Quarter 2024 Results and Highlights

06:00 ET premarket

91 LASR -23.50% against the close of 11/07/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings nLIGHT, Inc. Announces Third Quarter 2024 Results

16:05 ET after hours

92 EXAS -23.48% against the close of 11/05/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Exact Sciences Announces Third-Quarter 2024 Results

16:05 ET after hours

93 SLE -23.28% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Super League Announces Third Quarter 2024 Financial Results

16:20 ET after hours

94 ZETA -23.19% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Other Announcement Zeta Accelerates Revenue Growth to 42% and Achieves the “Rule of 60” in 3Q’24

16:05 ET after hours

95 EWCZ -23.16% against the close of 11/13/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings European Wax Center, Inc. Reports Third Quarter Fiscal Year 2024 Results

06:00 ET premarket

96 AKYA -23.00% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Akoya Biosciences Reports Third Quarter 2024 Financial Results

16:00 ET after hours

97 NNE -22.89% against the close of 11/22/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Offering / Dilution NANO Nuclear Energy Announces $60 Million Private Placement with Three Accredited Institutional Investors

09:00 ET premarket

98 IVAC -22.88% against the close of 11/11/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Leadership Change Intevac Announces Appointment of Ryan L. Vardeman to Board of Directors

16:02 ET after hours

99 AISP -22.87% against the close of 11/14/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Earnings Airship AI Reports Third Quarter 2024 Financial Results

16:05 ET after hours

100 LEV More than one ranked move this month 2+ ranked moves -22.63% against the close of 11/19/2024 session reconstructed
Session detail
Market cap is not shown on months older than a year, because only today's figure exists.
Uplisting / Compliance NYSE to Commence Delisting Proceedings with Respect to the Warrants of Lion Electric (LEV.WS)

06:30 ET premarket

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today. 920 smaller events this month are held out of this month's eligible pool; switch to include them. 259 events never entered this month's eligible pool, because the ticker is a warrant, a unit, a right or a preferred rather than common stock, or carries a stored capitalization above $10 trillion, which is larger than any company has reached. Include the $5M to $25M band

1 event was left out of this board because the price series changes basis between the baseline close and the measured one, so the two prices do not describe the same shares of the same company and their ratio measures a corporate action, or a change in what the ticker identifies, rather than a move.

Company names are not shown on months older than a year, because only the current holder of each ticker is known.

In November 2024, the median decliner was 3.4% deeper below its pre-news close five sessions later; the largest catalyst group was Earnings, 56 of the 100 events, at a median of -28.3%.

Close-to-close change on the measured trading session, against the previous close.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

Which catalysts drove the board

Swipe the table sideways for the day +5 columns.

Catalyst Events Share of board Median move close to close Median at day +5 Still below the pre-news close at day +5
Earnings 56 56.0% -28.3% -31.1% 96.4% of 56
Clinical Trial Results 13 13.0% -45.0% -44.7% 100.0% of 13
Other Announcement 11 11.0% -27.0% Only 9 of these 11 events have a five-session follow-up, so no median is shown. Only 9 of these 11 events have a five-session follow-up, so no share is shown.
Offering / Dilution 8 8.0% Fewer than 10 events in this group, so no figures are shown.
M&A / Acquisition 3 3.0% Fewer than 10 events in this group, so no figures are shown.

The day +5 figures are measured over the events in each group that have a five-session close, the count printed beside them, not over every event in the group.

5 other catalyst types, 9 events: FDA & Regulatory, Contract / Partnership, Uplisting / Compliance, Leadership Change, Buyback / Dividend.

How much of the drop held

Horizon Still below the pre-news close close to close Median change since the measured close as a share of the drop
Day +1 100.0% of 99 4.0% deeper below baseline, of 99
Day +5 94.9% of 98 3.4% deeper below baseline, of 98
Month end 95.9% of 98 2.7% recovered, of 98
Month end falls before day +5 for 9 of these 98 events, so this row is not a later horizon than the one above it. 98 of the 100 events have a month-end close later than the measured session; 2 have no month-end close.

Both figures in a row are measured over the events that have a close at that horizon, the count printed beside each of them, not over all 100 events on this board, which is why the denominators differ between rows.

Repeat runners

Some companies move on news more than once. The left list holds the ones that moved twice or more this month; the right list holds the ones that also moved in the months before it. The ranking above shows one row per move, so a name that keeps coming back is only visible here.

Moved twice or more inside November 2024

Two or more ranked moves this month, each on a different trading day.

SymbolMeasured sessionsLargest drop
NGNE 2Clinical Trial Results -44.08%
PACS 2Other Announcement, M&A / Acquisition -38.76%
LEV 2Earnings, Uplisting / Compliance -27.67%

Also fallen on news in earlier months

Ranked in at least two of the three months before this one. They are listed whether or not they rank this month, which is why the months are named.

SymbolMonthsLargest drop
LASE 2024-10, 2024-09, 2024-08 -38.81%
STEM 2024-10, 2024-09, 2024-08 -40.81%
HSDT 2024-10, 2024-09 -22.05%
UAVS 2024-10, 2024-09 -64.57%
VRCAthis month too 2024-10, 2024-08 -40.80%
ACHC 2024-10, 2024-09 -18.03%
QNTM 2024-10, 2024-08 -27.01%
FFIE 2024-09, 2024-08 -31.74%
CLNN 2024-09, 2024-08 -23.47%
AILEthis month too 2024-09, 2024-08 -53.29%
DPRO 2024-09, 2024-08 -36.27%

What the board was made of

Price before the move

Price bands are not shown on months older than a year, because the stored prices are adjusted for splits done since and a company that has reverse-split lands in a band its shares never traded in.

When the announcement landed

  • Pre-market44.0%
  • Intraday3.0%
  • After hours53.0%

Volume against normal

  • Under 5x16 events, 16.0%
  • 5x to 20x68 events, 68.0%
  • Over 20x16 events, 16.0%

Industry

  • Pharmaceutical Preparations20 events, 20.0%
  • Services-prepackaged Software7 events, 7.0%
  • Biological Products, (no Diagnostic Substances)6 events, 6.0%
  • Communications Equipment, Nec2 events, 2.0%
  • Electric Services2 events, 2.0%
  • Radio & Tv Broadcasting & Communications Equipment2 events, 2.0%

45 other industries, 50 events

Industry not known: 11.0%

4 events on this board carry the flag for a move that ran against its own release, too few to say whether the flag predicts anything.

Against October 2024

100 events in the comparable window.

October 2024 median -22.3%, selected from the 9,817 events in that month's eligible pool

November 2024 median -29.0%, 6.7 points steeper than October 2024. November 2024's median is taken over the 100 ranked rows, selected from the 8,958 events in that month's eligible pool.

How this ranking is measured

Close-to-close change on the measured trading session, against the previous close.

  • An announcement before 16:00 ET is measured on that trading day; one at or after 16:00 ET, or on a weekend, is measured on the next trading day.
  • One row per company and measured session. Other announcements the company made in the same session are listed inside the row.
  • A ranking is a coincidence of news and price on the same session, not proof that the news caused the move. Part of an intraday move can precede the announcement.
  • No Stated Cause marks a release in which the company itself says it knows of no reason for the move, while Other Announcement marks a release these rules could not classify.

Eligibility uses each company's capitalization today, not its capitalization at the time. Archive boards can therefore change as companies grow or shrink.

Prices are adjusted for stock splits the company has done since, so an older row's dollar figures are stated on today's share count and are not the prices that traded that day. The percentage move, the dollar volume and the relative volume are unaffected, because both prices carry the same adjustment. The session's share count carries the adjustment too, so the shares figure beside the dollar volume is that count restated on today's basis rather than the number of shares that changed hands. Where the ticker was retired the price series stops with it and no later adjustment reached it, so those rows are marked as traded and their dollars are the ones that changed hands on the day.

Market cap is not shown on months older than a year, because only today's figure exists.

NYSE and Nasdaq companies with a market capitalization of $25M or more, measured today. The exchange is the one recorded on each announcement, and a release naming several tickers records one venue for all of them. A session that changed hands for less than $25,000 in total is not ranked, because a percentage set by a handful of shares is a print rather than a move. On a board older than a year a fund is identified by its name alone, because an instrument class describes whoever holds the ticker today.

On 100 of these rows the measured session was reconstructed from the announcement time, because it predates our stored session records.

This archive starts at 2020-04, the first month with ranked moves.